康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02162 康诺亚-B

未开盘 07-22 16:08:56

32.000

-0.050

-0.16%

最高32.950	最低31.650	成交量60.35万
今开32.050	昨收32.050	日振幅4.06%
总市值89.52亿	流通市值89.52亿	总股本2.80亿
成交额1,956万	换手率0.22%	流通股本2.80亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02162","market":"HK","secType":"STK","nameCN":"康诺亚-B","latestPrice":32,"timestamp":1721635736030,"preClose":32.05,"halted":0,"volume":603500,"delay":0,"floatShares":279735566,"shares":279735566,"eps":-1.471316,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.05,"latestTime":"07-22 16:08:56","open":32.05,"high":32.95,"low":31.65,"amount":19560975,"amplitude":0.040562,"askPrice":32.05,"askSize":11500,"bidPrice":32,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-1.47131600473127,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1625673600000,"adjPreClose":32.05,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.688251,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02162","defaultTab":"news","newsList":[{"id":"2452449907","title":"康诺亚-B：获 1.85 亿美元合作款项，涨 5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452449907","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452449907?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:33","pubTimestamp":1721194425,"startTime":"0","endTime":"0","summary":"【康诺亚-B午后上涨 5.09%，现报 33.05 港元，成交额 1902.73 万港元】7 月 9 日，康诺亚宣布与 Belenos Biosciences 订立许可协议，授予后者全球研究、开发、注册、生产及商业化 CM512 及 CM536 两款双抗的独家权利。作为对价，康诺亚将收取 1500 万美元的首付款和近期付款，其全资附属公司一桥香港将收取 Belenos 约 30.01%的股权。此外，根据项目的开发、监管及商业里程碑达成情况，康诺亚有望获得最多 1.70 亿美元的额外付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171351549f5b5629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171351549f5b5629&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","02162","BK1161","BK1583"],"gpt_icon":0},{"id":"2452901051","title":"康诺亚-B午后涨超5% 已与Belenos Biosciences订立许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2452901051","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452901051?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:13","pubTimestamp":1721193211,"startTime":"0","endTime":"0","summary":"康诺亚-B（02162）午后上涨5.09%，现报33.05港元，成交额1902.73万港元。\n　　7月9日，康诺亚宣布已与Belenos Biosciences订立许可协议，授予后者在全球（不包括大中华地区）研究、开发、注册、生产及商业化CM512及CM536两款双抗的独家权利。\n　　据悉，作为对价，康诺亚将收取1500万美元的首付款和近期付款，而其全资附属公司一桥香港将收取Belenos约30.01%的股权；此外，根据项目的开发、监管及商业里程碑达成情况，康诺亚亦有望获得最多1.70亿美元的额外付款。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-17/doc-incemisy0475878.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-17/doc-incemisy0475878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02162","BK1574","BK1587","BK1161","BK1583"],"gpt_icon":0},{"id":"2452948905","title":"港股异动 | 康诺亚-B(02162)现涨超6% 与Belenos签订独家授权协议 海外授权两款自免双抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2452948905","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452948905?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:57","pubTimestamp":1721188678,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康诺亚-B(02162)现涨超6%，截止发稿，涨5.88%，报33.3港元，成交额1703.8万港元。消息面上，7月9日，康诺亚宣布已与Belenos Biosciences订立许可协议，授予后者在全球（不包括大中华地区）研究、开发、注册、生产及商业化CM512及CM536两款双抗的独家权利。据悉，作为对价，康诺亚将收取1500万美元的首付款和近期付款，而其全资附属公司一桥香港将收取Belenos约30.01%的股权；此外，根据项目的开发、监管及商业里程碑达成情况，康诺亚亦有望获得最多1.70亿美元的额外付款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["YANG","HSTECH","BK1161","HSCEI","02162","BK1587","07226","BK1583","BK1574"],"gpt_icon":0},{"id":"2452903826","title":"康诺亚-B(02162)上涨5.25%，报33.1元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452903826","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452903826?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:25","pubTimestamp":1721186745,"startTime":"0","endTime":"0","summary":"7月17日，康诺亚-B(02162)盘中上涨5.25%，截至11:25，报33.1元/股，成交1451.2万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法，主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项，其中9项已进入不同阶段临床研发，多项位于中国第一，世界前三，包含一项世界首创ADC新药，两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2023年年报，康诺亚-B营业总收入3.54亿元、净利润-3.59亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/17112541613484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02162","BK1587","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2452903874","title":"康诺亚-B盘中异动 股价大涨5.09%报33.050港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452903874","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452903874?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:25","pubTimestamp":1721186744,"startTime":"0","endTime":"0","summary":"2024年07月17日早盘11时25分，康诺亚-B股票出现波动，股价快速拉升5.09%。截至发稿，该股报33.050港元/股，成交量44.7万股，换手率0.16%，振幅4.93%。资金方面，该股资金流入809.145万港元，流出491.615万港元。康诺亚-B股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，百奥赛图-B、泰格医药、永泰生物-B涨幅较大，振幅较大的相关个股有盛禾生物-B、百奥赛图-B、维亚生物，振幅分别为16.10%、9.30%、7.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717112544941f7b46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717112544941f7b46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1583","02162","BK1161","BK1574"],"gpt_icon":0},{"id":"2452456903","title":"康诺亚－Ｂ(02162)股价上升5.246%，现价港币$33.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2452456903","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452456903?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:25","pubTimestamp":1721186700,"startTime":"0","endTime":"0","summary":"[上升股]康诺亚－Ｂ(02162) 股价在上午11:25比前收市价上升5.246%，现股价为港币$33.1。至目前为止，今日最高价为$33.1，而最低价为$31.45。总成交量为44.75万股，总成交金额为港币$1.453千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240717865/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02162","BK1583","BK1161","BK1574","BK1587"],"gpt_icon":0},{"id":"2451235613","title":"康诺亚-B07月15日遭主力抛售423万元 环比增加415.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451235613","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451235613?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:15","pubTimestamp":1721031340,"startTime":"0","endTime":"0","summary":"07月15日, 康诺亚-B股价跌8.14%，报收31.60元，成交金额6202万元，换手率0.70%，振幅9.45%，量比2.21。康诺亚-B今日主力资金净流出423万元，上一交易日主力净流出82万元，今日环比增加415.85%。该股近5个交易日上涨1.27%，主力资金累计净流出339万元；近20日主力资金累计净流出423万元，其中净流出天数为8日。该股主力净额占比0.05%，港股市场排名2580/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071516160595bf2a2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071516160595bf2a2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","02162","BK1574","BK1583"],"gpt_icon":0},{"id":"2451699139","title":"康诺亚－Ｂ(02162)股价下跌9.157%，现价港币$31.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2451699139","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451699139?lang=zh_cn&edition=full","pubTime":"2024-07-15 14:28","pubTimestamp":1721024880,"startTime":"0","endTime":"0","summary":"[下跌股]康诺亚－Ｂ(02162) 股价在下午02:28比前收市价下跌9.157%，现股价为港币$31.25。至目前为止，今日最高价为$34.3，而最低价为$31.25。总成交量为145.05万股，总成交金额为港币$4.653千万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2407151452/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1587","02162","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2451623650","title":"康诺亚-B(02162)下跌5.09%，报32.65元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451623650","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451623650?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:38","pubTimestamp":1721007521,"startTime":"0","endTime":"0","summary":"7月15日，康诺亚-B(02162)盘中下跌5.09%，截至09:38，报32.65元/股，成交329.98万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法，主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项，其中9项已进入不同阶段临床研发，多项位于中国第一，世界前三，包含一项世界首创ADC新药，两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2023年年报，康诺亚-B营业总收入3.54亿元、净利润-3.59亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/15093841565441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1587","02162","BK1161","BK1574"],"gpt_icon":0},{"id":"2451657315","title":"康诺亚-B盘中异动 股价大跌8.87%报31.351港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451657315","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451657315?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:31","pubTimestamp":1721007078,"startTime":"0","endTime":"0","summary":"2024年07月15日早盘09时31分，康诺亚-B股票出现波动，股价快速下挫8.87%。截至发稿，该股报31.351港元/股，成交量1.85万股，换手率0.01%，振幅8.58%。资金方面，该股资金流入1.6925万港元，流出43.5675万港元。康诺亚-B股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，金斯瑞生物科技、加科思-B、康希诺生物涨幅较大，振幅较大的相关个股有金斯瑞生物科技、康诺亚-B、来凯医药-B，振幅分别为17.80%、8.58%、5.01%。该公司主要产品包括CM310、CM326以及CMG901等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715093118aef9a02b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715093118aef9a02b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1587","02162","BK1583"],"gpt_icon":0},{"id":"2450305651","title":"港股收盘(07.12) | 恒指收涨2.59% 科网、内房股等表现强势 龙湖集团(00960)领涨蓝筹","url":"https://stock-news.laohu8.com/highlight/detail?id=2450305651","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450305651?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:44","pubTimestamp":1720773896,"startTime":"0","endTime":"0","summary":"蓝筹股表现龙湖集团领涨蓝筹。截至收盘，涨8.39%，报11.52港元，成交额1.71亿港元，贡献恒指3.44点。截至收盘，世茂集团涨14.29%，报0.8港元；新城发展涨9.35%，报1.52港元；龙湖集团涨8.39%，报11.52港元；雅居乐集团涨7.84%，报0.55港元。截至收盘，山东黄金跌2.59%，报16.54港元；中国黄金国际跌2%，报51.45港元；紫金矿业跌0.23%，报17.58港元。截至收盘，涨6.37%，报49.25港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0463099449.HKD","IE0008369823.USD","YANG","IE00B29SXG58.USD","HSTECH","01138","IE0031814852.USD","LU0320764599.SGD","LU0862451753.SGD","LU0593848301.USD","HSCEI","LU0572944931.SGD","LU0384037296.USD","01038","BK1583","LU0348827113.USD","LU0244354667.USD","LU0359202008.SGD","00960","BK1555","BK1507","LU0229945570.USD","LU0456827905.SGD","LU0140636845.USD","LU0348816934.USD","02833","LU0348805143.USD","BK1544","01787","HHImain","MCHmain","BK1521","HSI","IE00B5MMRT66.SGD","LU0231483743.USD","07226","BK1569","BK1099","513600","BK1587","LU0327786744.USD","LU0823426480.USD","LU0051755006.USD","LU0359201612.USD","02162","03143","LU0417516738.SGD","IE00B031HY20.USD","BK1240","03968"],"gpt_icon":0},{"id":"2450282853","title":"康诺亚-B早盘涨超4% 与Belenos签订独家授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2450282853","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450282853?lang=zh_cn&edition=full","pubTime":"2024-07-12 10:40","pubTimestamp":1720752042,"startTime":"0","endTime":"0","summary":"康诺亚-B（02162）早盘上涨4.46%，现报33.95港元，成交额2270.82万港元。\n　　根据康诺亚生物官网披露，公司已与Belenos就两款自主研发的双特异性抗体订立许可协议，根据协议条款：康诺亚授予Belenos在全球（除大中华地区）开发、生产及商业化临床前阶段药物CM512及CM536的独家权利。\n　　据悉，作为对价，康诺亚将收取1500万美元的首付款和近期付款，而其全资附属公司一桥香港将收取Belenos约30.01%的股权；此外，根据项目的开发、监管及商业里程碑达成情况，康诺亚亦有望获得最多1.70亿美元的额外付款。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-12/doc-inccvttz7966477.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-12/doc-inccvttz7966477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1583","BK1587","BK1574","02162","BK1161"],"gpt_icon":0},{"id":"2450340143","title":"港股异动 | 康诺亚-B(02162)现涨近6% 与Belenos签订独家授权协议 海外授权两款自免双抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2450340143","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450340143?lang=zh_cn&edition=full","pubTime":"2024-07-12 10:16","pubTimestamp":1720750595,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康诺亚-B(02162)现涨近6%，截至发稿，涨5.54%，报34.3港元，成交额1937.11万港元。消息面上，根据康诺亚生物官网披露，公司已与Belenos就两款自主研发的双特异性抗体订立许可协议，根据协议条款：康诺亚授予Belenos在全球(除大中华地区)开发、生产及商业化临床前阶段药物CM512及CM536的独家权利。据悉，作为对价，康诺亚将收取1500万美元的首付款和近期付款，而其全资附属公司一桥香港将收取Belenos约30.01%的股权；此外，根据项目的开发、监管及商业里程碑达成情况，康诺亚亦有望获得最多1.70亿美元的额外付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02162","BK1574","BK1587","BK1583","HSCEI","BK1161","07226","HSTECH","YANG"],"gpt_icon":0},{"id":"2450959347","title":"康诺亚-B盘中异动 早盘大幅上涨5.08%报34.151港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450959347","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450959347?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:52","pubTimestamp":1720749126,"startTime":"0","endTime":"0","summary":"2024年07月12日早盘09时52分，康诺亚-B股票出现异动，股价快速上涨5.08%。截至发稿，该股报34.151港元/股，成交量22.1万股，换手率0.08%，振幅4.15%。康诺亚-B股票所在的生物技术行业中，整体涨幅为1.42%。消息层面，截至09时52分，《康诺亚-B与Belenos订立有关CM512及CM536的独家许可协议》资讯为影响康诺亚-B的重要信息。就许可协议而言，Belenos与成都康诺亚将订立供应协议，据此，Belenos将有权向成都康诺亚或其合同生产商采购所需数量的CM512及CM536以便进行该等临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712095206af91f5f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712095206af91f5f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1587","BK1574","02162","BK1161"],"gpt_icon":0},{"id":"2450342733","title":"康诺亚-B(02162)上涨5.08%，报34.15元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450342733","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450342733?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:52","pubTimestamp":1720749126,"startTime":"0","endTime":"0","summary":"7月12日，康诺亚-B(02162)盘中上涨5.08%，截至09:52，报34.15元/股，成交742.66万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法，主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项，其中9项已进入不同阶段临床研发，多项位于中国第一，世界前三，包含一项世界首创ADC新药，两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2023年年报，康诺亚-B营业总收入3.54亿元、净利润-3.59亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/12095241531565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1587","BK1574","02162","BK1161","BK1583"],"gpt_icon":0},{"id":"2450881272","title":"恒生医药持仓股康诺亚两款双抗授权出海，交易额共计1.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450881272","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450881272?lang=zh_cn&edition=full","pubTime":"2024-07-10 09:52","pubTimestamp":1720576366,"startTime":"0","endTime":"0","summary":"7月9日，康诺亚的全资附属公司与Belenos Biosciences公司订立许可协议。康诺亚授予Belenos在全球（除大中华地区）开发、生产及商业化CM512及CM536两款双抗的独家权利，交易额共计约1.85亿美元，折合人民币约13.5亿元。恒生医药ETF（159892）持仓再鼎医药、云顶新耀、康诺亚、康方生物等诸多尚未在A股上市的、创新属性突出的标的，其跟踪指数当前处于历史估值低位，有望受益于创新、出海主线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100952589f29704c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100952589f29704c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1587","02162","BK1161","BK1515","09939","BK1574"],"gpt_icon":0},{"id":"2450094784","title":"康诺亚-B07月09日获主力加仓107万元 环比增加494.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450094784","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450094784?lang=zh_cn&edition=full","pubTime":"2024-07-09 16:16","pubTimestamp":1720513016,"startTime":"0","endTime":"0","summary":"07月09日, 康诺亚-B股价涨1.91%，报收32.00元，成交金额2587万元，换手率0.29%，振幅5.73%，量比1.41。康诺亚-B今日主力资金净流入107万元，上一交易日主力净流入18万元，今日环比增加494.44%。该股近5个交易日下跌0.62%，主力资金累计净流入190万元；近20日主力资金累计净流入12万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091617249f2422c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091617249f2422c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02162","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2450051262","title":"【港股通】康诺亚(02162)涨逾5% 与Belenos订立有关CM512及CM536的独家许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2450051262","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450051262?lang=zh_cn&edition=full","pubTime":"2024-07-09 10:26","pubTimestamp":1720491985,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康诺亚 走势向好，截至发稿，报33.05港元，涨5.25%，成交额1007.08万港元。消息面上，2024年7月9日，康诺亚生物医药科技(成都)有限公司与Belenos Biosciences, Inc.已订立许可协议。在许可协议的条款及条件规限下，Belenos获授CM512及CM536在许可地区的研究、开发、注册、生产及商业化的独家许可。作为对价，成都康诺亚将收取15百万美元的首付款和近期付款，而一桥香港控股有限公司将收取Belenos约30.01%的股权。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200908/MDgyM2JhZGUzZDEwMDQ3MDAxNzk5NzY4NzQxNTI4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgyM2JhZGUzZDEwMDQ3MDAxNzk5NzY4NzQxNTI4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940021","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","07226","HSTECH","BK1574","HSCEI","BK1587","YANG","BK1161","BK1583"],"gpt_icon":0},{"id":"2450974055","title":"康诺亚-B现涨超5% 附属与Belenos Biosciences, Inc.订立许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2450974055","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450974055?lang=zh_cn&edition=full","pubTime":"2024-07-09 09:44","pubTimestamp":1720489440,"startTime":"0","endTime":"0","summary":"　　康诺亚-B早盘持续走高，股价上涨5.26%，现报33.05港元，成交额452.74万港元。　　康诺亚宣布，其全资附属成都康诺亚与Belenos Biosciences， Inc．订立许可协议，授予Belenos在全球开发、生产及商业化集团候选药物CM512及CM536的独家权利。　　作为对价，成都康诺亚将收取1500万美元的首付款和近期付款，而另一全资附属一桥香港将收取Belenos约30.01%的股权。于CM512及CM536首次商业销售后开始的指定时间段内，成都康诺亚亦有权从Belenos收取销售净额的分层特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-09/doc-inccnwhp8951606.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-09/doc-inccnwhp8951606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1587","BK1161","02162","BK1583"],"gpt_icon":0},{"id":"2450055447","title":"康诺亚-B盘中异动 早盘快速拉升5.74%报33.201港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450055447","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450055447?lang=zh_cn&edition=full","pubTime":"2024-07-09 09:40","pubTimestamp":1720489208,"startTime":"0","endTime":"0","summary":"2024年07月09日早盘09时40分，康诺亚-B股票出现波动，股价快速上涨5.74%。截至发稿，该股报33.201港元/股，成交量10.75万股，换手率0.04%，振幅5.73%。康诺亚-B股票所在的生物技术行业中，整体涨幅为0.07%。就许可协议而言，Belenos与成都康诺亚将订立供应协议，据此，Belenos将有权向成都康诺亚或其合同生产商采购所需数量的CM512及CM536以便进行该等临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709094009941f512a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709094009941f512a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1583","BK1574","02162"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":-0.0751},{"period":"3month","weight":-0.0093},{"period":"6month","weight":-0.0303},{"period":"1year","weight":-0.3476},{"period":"ytd","weight":-0.3483}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Keymed Biosciences Inc是一家中国生物科技公司。该公司专注于自主发现及开发创新生物疗法以满足自体免疫及肿瘤治疗领域中未获满足的医疗需求。该公司已掌握内部药物发现及开发技术，其中包括构成其创新抗体发现平台及自有新型T细胞重定向(nTCE)双特异性抗体平台的技术。该公司还建立了涵盖生物药开发的关键功能的全面一体化平台。该公司主要产品包括CM310、CM326以及CMG901等。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.102216},{"month":2,"riseRate":0.666667,"avgChangeRate":0.052845},{"month":3,"riseRate":0,"avgChangeRate":-0.111304},{"month":4,"riseRate":1,"avgChangeRate":0.048679},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.125967},{"month":6,"riseRate":1,"avgChangeRate":0.150041},{"month":7,"riseRate":0.333333,"avgChangeRate":0.07197},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.018956},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.014017},{"month":10,"riseRate":0.666667,"avgChangeRate":0.069277},{"month":11,"riseRate":0.666667,"avgChangeRate":0.090203},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.129089}],"exchange":"SEHK","name":"康诺亚-B","nameEN":"KEYMED BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康诺亚-B,02162,康诺亚-B股票,康诺亚-B股票老虎,康诺亚-B股票老虎国际,康诺亚-B行情,康诺亚-B股票行情,康诺亚-B股价,康诺亚-B股市,康诺亚-B股票价格,康诺亚-B股票交易,康诺亚-B股票购买,康诺亚-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}